HOWL Archived Articles
Werewolf Therapeutics (NASDAQ:HOWL) - Pioneering Conditionally Activated Therapeutics to Revolutionize Immuno-Oncology
Published on March 13, 2025
Werewolf Therapeutics (HOWL): Pioneering Immune-Stimulating Therapies with Promising Pipeline and Robust Financial Position
Published on November 17, 2024
Werewolf Therapeutics, Inc. (NASDAQ:HOWL): A Promising Biopharmaceutical Company Pioneering Innovative Cancer Therapies
Published on September 24, 2024